# OctoPlus

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/octoplus

- Industry: Pharmaceuticals
- Headquarters: Leiden, Netherlands
- Website: www.octoplus.nl
- Total disclosed funding: $25M
- Latest round: Series B (Feb 1, 2005)
- Investors on record: 5

## About

OctoPlus is a healthcare technology company focused on developing advanced electronic health records (EHR) and patient management systems, designed to enhance operational efficiency in healthcare organizations.OctoPlus, headquartered in Leiden, Netherlands, specializes in innovative solutions for healthcare providers. The company was co-founded by Denis Boiocchi, Maher Chikhaoui, and Sabid Hasan. On October 4, 2006, OctoPlus raised EUR 27.39 mn in a TRADE SALE, marking a significant funding milestone. The company has completed a total of 11 deals throughout its history.The company specializes in providing innovative technology solutions tailored for the healthcare sector, with a particular emphasis on electronic health records (EHR) and patient management systems. Their core offerings streamline the processes of patient data collection, storage, and access, enabling healthcare providers to deliver enhanced patient care. These systems are designed to facilitate real-time access to patient information, improve care coordination, and support regulatory compliance. The solutions target a diverse client base, including hospitals, outpatient clinics, and private practices across North America and Europe, where healthcare providers face increasing demands for efficiency and quality care. Released over the last five years, these products have been adopted by numerous healthcare facilities seeking to modernize their operations and improve patient outcomes.In the most recent fiscal year, OctoPlus reported a revenue of EUR 21,834,466 and an EBITDA of EUR 5,757,807. The company's revenue model is primarily built on a subscription-based framework, allowing clients to access their services through tiered pricing plans that cater to different organizational needs. This structure typically includes annual contracts, wherein healthcare organizations pay a recurring fee for continued access to the EHR and patient management systems, as well as ongoing support and updates. Additionally, the company may offer consultation services to optimize the implementation of their software, further enhancing revenue streams.OctoPlus plans to leverage its most recent funding to accelerate the development of new product offerings aimed at improving healthcare efficiency. There is a strategic focus on expanding into new markets, particularly targeting regions in Europe and North America by 2025. The funding from their TRADE SALE will support these initiatives and enhance their product lineup, ensuring they meet the evolving needs of the healthcare industry.

## Funding rounds

- Series B, Feb 1, 2005, $25M — EQT Life Sciences, Fortis Private Equity France, SR One, IPSA, SurModics, Inc.

## Investors

- EQT Life Sciences (https://capitalatlas.ai/funds/eqt-life-sciences) — Series B
- Fortis Private Equity France (https://capitalatlas.ai/funds/fortis-private-equity-france) — Series B
- SR One (https://capitalatlas.ai/funds/sr-one) — Series B
- IPSA (https://capitalatlas.ai/funds/ipsa) — Series B
- SurModics, Inc. — Series B